Browse Category

NYSE:BAYRY News 4 December 2025

Bayer Aktie Soars After U.S. Roundup Breakthrough: Latest News, Analyst Forecasts and 2026 Outlook (4 December 2025)

Bayer Aktie Soars After U.S. Roundup Breakthrough: Latest News, Analyst Forecasts and 2026 Outlook (4 December 2025)

Bayer’s share price has exploded higher in early December 2025 after the U.S. government unexpectedly sided with the company in its long‑running Roundup legal saga. For investors in Bayer Aktie (BAYN, BAYGN.DE, BAYRY), the move has transformed sentiment almost overnight – but the underlying story is still a complex mix of litigation risk, heavy debt, restructuring and a slowly improving pipeline. This article gives a news‑driven, SEO‑friendly overview of Bayer stock as of 4 December 2025, covering the latest headlines, financial results, analyst forecasts and the key bull and bear arguments around the shares. It is informational only and not investment advice. 1.

Stock Market Today

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

7 February 2026
Ashtead shares closed Friday at 4,936p, up 1.09%, after the company bought 88,872 shares under its repurchase program. The group is set to shift its primary listing to New York on March 2, pending court approval, and will be removed from the FTSE UK index the same day. Ashtead paid a half-year dividend of 37.5 U.S. cents per share on Friday.
Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

7 February 2026
Beazley shares closed flat at 1,236 pence Friday as BlackRock disclosed a 6.55% stake and Vanguard reported 5.02%. Wellington Management cut its holding below 5%. The disclosures follow Zurich Insurance’s possible takeover offer of up to 1,335 pence per share, with a Feb. 16 deadline for a firm bid.
Go toTop